newsfilter
← Latest News
GlobeNewswire·

Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination

NEW YORK and PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Hyperliquid Strategies Inc ("HSI" or the "Company") and Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet") today announced the completion of